SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

VIEIRA, Fátima Mendonça Jorge; AOKI, Valéria; OLIVEIRA, Zilda Najjar Prado de  and  MARTINS, José Eduardo Costa. Estudo da imunofluorescência direta, imunomapeamento e microscopia ótica na porfiria cutânea tardia. An. Bras. Dermatol. [online]. 2010, vol.85, n.6, pp. 827-837. ISSN 0365-0596.  http://dx.doi.org/10.1590/S0365-05962010000600008.

    1. Cormane RH, Szabò E, Hoo TT. Histopathology of skin in acquired and hereditary porphyria cutanea tarda. Br J Dermatol. 1971;85:531-9. [ Links ]

    2. Wolff K, Hönigsmann H, Rauschmeier W, Schuler G, Pechlaner R. Microscopic and fine structural aspects of porphyrias. Acta Derm Venereol Suppl (Stockh). 1982;100:17-28. [ Links ]

    3. Dabski C, Beutner EH. Studies of laminin and type IV collagen in blisters of porphyria cutanea tarda and drug-induced pseudoporphyria. J Am Acad Dermatol. 1991;25(1 Pt 1):28-32. [ Links ]

    4. Burgeson RE, Christiano AM. The Dermal-epidermal Junction. Curr Opin Cell Biol. 1997;9:651-8. [ Links ]

    5. Magnus IA. Dermatological Photobiology. Clinical and Experimental Aspects. Appendix II - Clinical Screening tests for excess porphyrins. London: Blackwell Scientific Publications; 1976. p.253-5. [ Links ]

    6. Bickers DR, Pathak MA. The porphyrias. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in General medicine. 4th ed. New York: McGraw-Hill; 1993. p.1854-93. [ Links ]

    7. Lim CK, Peters TJ. Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias. Clin Chim Acta. 1984;139:55-63. [ Links ]

    8. Vieira FMJ, Martins JEC. Porfiria cutânea tardia. An Bras Dermatol. 2006;81:573-84. [ Links ]

    9. Roengk HH Jr, Gottlob ME. Estrogen-induced porphyria cutanea tarda. Arch Dermatol. 1970;102:260-6. [ Links ]

    10. Chuang TY, Brashear R, Lewis C. Porphyria cutanea tarda and hepatitis C virus: A case-control study and meta-analysis of the literature. J Am Acad Dermatol. 1999;41:31-6. [ Links ]

    11. Mansourati FF, Stone VE, Mayer KH. Porphyria cutanea tarda and HIV/AIDS: a review of pathogenesis, clinical manifestations and management. Int J STD AIDS. 1999;10:51-6. [ Links ]

    12. Fracanzani AL, Taioli E, Sampietro M, Fatta E, Bertelli C, Fiorelli G, et al. Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease. J Hepatol. 2001;35:498-503. [ Links ]

    13. Kordac V, Papezová R, Semrádová M. Chloroquine in the treatment of porphyria cutanea tarda. N Eng J Med. 1977;296:949. [ Links ]

    14. Freesemann A, Frank M, Sieg I, Doss MO. Treatment of porphyria cutanea tarda by the effect of chloroquine on the liver. Skin Pharmacol. 1995;8:156-61. [ Links ]

    15. Timonen K, Niemi KM, Mustajoki P. Skin morphology in porphyria cutanea tarda does not improve despite clinical remission. Clin Exp Dermatol. 1991;16:355-8. [ Links ]

    16. Epstein JH, Tuffanelli DL, Epstein WL. Cutaneous changes in the porphyrias: A microscopic study. Arch Dermatol. 1973;107:689-98. [ Links ]

    17. Wick G, Hönigsmann H, Timpl R. Immunofluorescence demonstration of type IV collagen and a noncollagenous glycoprotein in thickened vascular basal membranes in protoporphyria. J Invest Dermatol. 1979;73:335-8. [ Links ]

    18. Hönigsmann H, Gschnaiat F, Konrad K, Stingl G, Wolff K. Mouse model for protoporphyria. III. Experimental production of chronic erythropoietic proto porphyrialike skin lesions. J Invest Dermatol. 1976; 66:188-95. [ Links ]

    19. Ryan EA. Histochemistry of the skin in erythropoietic protoporphyria. Br J Dermatol. 1966;78:501-18. [ Links ]

    20. Baart de la Faille-Kuyp, Cormane RH. The occurrence of certain serum factors in the dermal-epidermal junction and vessel walls of the skin in lupus eythematosus and other (skin) diseases. Acta Derm Venereol. 1968;48:578-88. [ Links ]

    21. Krajnc I, Vizjak A, Hvala A, Jurcic V, Rozman B. The significance of histologic analysis of skin lesions in porphyria cutanea tarda. Light microscopy, electron microscopy, immunohistochemical and immuno fluorescence analysis. Wien Klin Wochenschr. 1998;110:651-4. [ Links ]

    22. Lim HW, Perez HD, Poh-Fitzpatrick M, Goldstein IM, Gigli I. Generation of chemotactic activity in serum from patients with erythropoietic protoporphyria and porphyria cutanea tarda. N Engl J Med. 1981;304:212-6. [ Links ]

    23. Torinuki W, Miura T, Tagami H. Activation of complement by 405-nm light in serum from porphyria cutanea tarda. Arch Dermatol Res. 1985;277:174-8. [ Links ]

    24. Lim HW, Gigli I. Role of complement in porphyrin-induced photosensitivity. J Invest Dermatol. 1981;76:4-9. [ Links ]

    25. Lim HW, Poh-Fitzpatrick MB, Gigli I. Activation of the complement system in patients with porphyrias after irradiation in vivo. J Clin Invest. 1984;74:1961-5. [ Links ]

    26. Rimington C, Magnus IA, Ryan EA, Cripps DJ. Porphyria and photosensitivity. Q J Med. 1967;36:29-57. [ Links ]

    27. Klein GF, Hintner H, Schuler G, Fritsch P. Junctional blisters in acquired bullous disorders of the dermal-epidermal junction zone: role of the lamina lucida as the mechanical locus minoris resistentiae. Br J Dermatol. 1983;109:499-508. [ Links ]

    28. Nagato N, Nonaka S, Ohgami T, Murayama F, Yamashita K, Irifune H, et al. Mechanism of blister formation in porphyria cutanea tarda. I. Histopathological observation of blisters in three cases of porphyria cutanea tarda.. J Dermatol. 1987;14:551-5. [ Links ]

    29. Caputo R, Berti E, Gasparini G, Monti M. The morphologic events of blister formation in porphyria cutanea tarda. Int J Dermatol. 1983;22:467-72. [ Links ]

    30. Perrot H, Schmitt D, Thivolet J, Leung J, Germain DU. Étude ultrastructurale de la bulle dans les porphyries cutanées hépatiques. Bull Soc Fr Derm Syph. 1972;79:12-8. [ Links ]